NEW YORK (GenomeWeb News) – Proteomics technologies company LifeSensors has licensed technology from Spain's CICbioGUNE research center for use in purifying ubiquitylated proteins that are unstable and difficult to characterize.

LifeSensors said on Tuesday that it signed a worldwide, exclusive license for the Tandem-repeated Ubiquitin Binding Entities (TUBEs) technology, which was developed at CICbioGUNE's proteomics unit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.